Herbs that burn visceral fat are a popular topic in health media, but separating plausible science from marketing claims requires careful scrutiny. Visceral fat — the deep abdominal fat surrounding vital organs — is strongly linked to type 2 diabetes, cardiovascular disease, and other serious conditions. Whilst certain plant-derived compounds such as green tea catechins, curcumin, and berberine have identifiable biological mechanisms, the clinical evidence in humans remains modest and inconsistent. This article examines what the research actually shows, outlines important safety considerations, and explains what NHS and NICE guidance recommends for effectively reducing visceral fat.

What Is Visceral Fat and Why Does It Matter for Your Health?

Visceral fat is metabolically active fat stored deep in the abdominal cavity that raises risk of type 2 diabetes, cardiovascular disease, and NAFLD by releasing inflammatory cytokines and fatty acids into the portal circulation.

Visceral fat is the metabolically active adipose tissue stored deep within the abdominal cavity, surrounding vital organs such as the liver, pancreas, and intestines. Unlike subcutaneous fat — the layer you can pinch beneath the skin — visceral fat is not visible from the outside, yet it carries significantly greater health risks.

Visceral fat is commonly assessed using waist circumference. For White European adults, NICE guidance (CG189) identifies increased cardiometabolic risk at waist measurements above 94 cm in men and 80 cm in women. However, these thresholds are lower for some ethnic groups: for South Asian, Chinese, and Japanese men, for example, a threshold of 90 cm is used in UK clinical practice, reflecting higher metabolic risk at lower waist measurements. Women from these groups share the same 80 cm threshold as White European women.

NICE also recommends using waist-to-height ratio (WHtR) alongside BMI to assess weight-related health risk. A WHtR below 0.5 is generally considered healthy; 0.5 to below 0.6 indicates high risk; and 0.6 or above indicates very high risk. To measure your waist correctly, find the midpoint between the bottom of your lowest rib and the top of your hip bone, breathe out naturally, and measure without pulling the tape tight.

Excess visceral fat is strongly associated with a range of serious health conditions, including:

• Type 2 diabetes — visceral fat contributes to insulin resistance by releasing free fatty acids and pro-inflammatory cytokines directly into the portal circulation

• Cardiovascular disease — elevated levels are linked to dyslipidaemia, hypertension, and atherosclerosis

• Non-alcoholic fatty liver disease (NAFLD)

• Certain cancers, including colorectal and endometrial cancer

Visceral fat is biologically distinct from other fat depots because it is highly lipolytically active, meaning it releases fatty acids rapidly in response to hormonal signals. It also secretes adipokines — signalling molecules such as leptin, adiponectin, and resistin — that influence inflammation, appetite regulation, and glucose metabolism. Understanding this biological context is important when evaluating whether any dietary supplement or herbal remedy can meaningfully target this specific fat depot, as the mechanisms involved are complex and multifactorial.

Herbs Commonly Associated With Visceral Fat Reduction

Green tea catechins, berberine, curcumin, ginger, and cinnamon are the most studied herbs, but none are approved for visceral fat reduction by UK or European regulatory authorities.

A number of herbs and plant-derived compounds are frequently cited in popular health media as having the potential to reduce visceral fat. It is important to approach these claims with measured scepticism, whilst acknowledging that some have plausible biological mechanisms that have been explored in preliminary research. In most cases, the evidence comes from small trials, animal studies, or cell cultures, and effect sizes in humans are modest at best.

Green tea (Camellia sinensis) is perhaps the most widely studied. It contains catechins — particularly epigallocatechin gallate (EGCG) — and caffeine, which together may modestly increase thermogenesis and fat oxidation. A Cochrane review and several meta-analyses have found small, statistically significant reductions in body weight and abdominal fat with green tea catechins, though the absolute effect sizes are modest and unlikely to be clinically meaningful without accompanying lifestyle changes.

Turmeric (Curcuma longa) contains curcumin, a polyphenol with anti-inflammatory properties. Since chronic low-grade inflammation is closely linked to visceral fat accumulation, curcumin has attracted research interest. However, its very poor oral bioavailability limits practical effect, and human trial evidence remains of low certainty.

Ginger (Zingiber officinale) has been studied for its potential to improve insulin sensitivity and reduce inflammatory markers, both of which are relevant to visceral fat metabolism. Evidence is largely from small, short-duration trials.

Other herbs commonly mentioned include:

• Cinnamon — some meta-analyses suggest modest improvements in fasting blood glucose and insulin sensitivity, though effects on visceral fat specifically are not established

• Fenugreek — contains soluble fibre that may support satiety and blood glucose regulation; human evidence is limited

• Black pepper (piperine) — often combined with curcumin to enhance its absorption; any thermogenic effect in humans is preliminary and small in magnitude

• Berberine — a plant alkaloid found in several herbs (including barberry and goldenseal), studied for effects on glucose metabolism and lipid profiles in people with type 2 diabetes and metabolic syndrome; it is not licensed for obesity in the UK and product quality and standardisation may vary considerably

Whilst these herbs have identifiable pharmacological properties, it is essential to distinguish between a plausible mechanism and proven clinical efficacy in reducing visceral fat specifically. None are approved for this purpose by UK or European regulatory authorities.

What Does the Clinical Evidence Actually Show?

Clinical evidence for herbs reducing visceral fat is limited and methodologically weak; green tea extracts have the most robust data, but absolute effects are modest and not clinically meaningful without lifestyle changes.

The clinical evidence base for herbs specifically reducing visceral fat in humans remains limited, inconsistent, and often methodologically weak. Most studies are small, short in duration, conducted in specific populations (such as those with metabolic syndrome), and frequently funded by supplement manufacturers — all factors that introduce significant bias.

Green tea extracts have the most robust evidence. A Cochrane review and subsequent meta-analyses have found statistically significant but modest reductions in body weight and abdominal fat with green tea catechins, particularly when combined with caffeine. Typical absolute changes reported are in the region of 0.2–0.5 kg body weight and small reductions in waist circumference over 12 weeks. These effects are unlikely to be clinically meaningful without accompanying lifestyle changes.

Berberine has shown more promising results in trials involving individuals with type 2 diabetes and metabolic syndrome, with some studies demonstrating reductions in waist circumference and visceral fat area on imaging. However, these trials are predominantly conducted in East Asian populations, limiting generalisability to UK patients, and berberine is not licensed or recommended by NICE or the MHRA for obesity or visceral adiposity.

For curcumin, ginger, and cinnamon, the evidence is largely preclinical (animal studies or cell cultures) or derived from very small human trials with high risk of bias. There is currently no robust, large-scale randomised controlled trial (RCT) evidence supporting their use as standalone interventions for visceral fat reduction.

Importantly, no herbal supplement is licensed by the MHRA or recommended by NICE for the treatment of obesity or visceral adiposity. The European Medicines Agency (EMA) similarly does not endorse herbal products for this indication. Any weight-related benefits observed in studies are generally modest and appear most effective when used alongside — not instead of — dietary modification and physical activity.

Safety Considerations and Potential Interactions With Medicines

High-dose green tea extract can cause liver injury, berberine may potentiate antidiabetic and antihypertensive drugs, and curcumin may interact with warfarin — always consult a GP or pharmacist before use.

Herbal supplements are widely perceived as natural and therefore safe, but this assumption can be misleading. Many plant-derived compounds are pharmacologically active and carry genuine risks, particularly when taken alongside prescribed medicines or in individuals with underlying health conditions.

Green tea extracts in high-dose supplement form (as opposed to drinking tea) have been associated with hepatotoxicity. The MHRA has issued a Drug Safety Update warning about the risk of liver injury with green tea extract products. If you develop symptoms such as jaundice, dark urine, persistent nausea, or abdominal pain whilst taking a green tea extract supplement, stop taking it and seek medical advice promptly. Individuals with existing liver conditions should exercise particular caution.

Berberine can lower blood glucose and blood pressure, meaning it may potentiate the effects of antidiabetic medications (such as metformin or insulin) and antihypertensives, increasing the risk of hypoglycaemia or hypotension.

Turmeric/curcumin at supplemental doses may:

• Interact with anticoagulants such as warfarin — there are case reports and theoretical mechanisms suggesting increased bleeding risk, though robust clinical evidence is limited; caution is warranted

• Affect cytochrome P450 enzymes, potentially altering the metabolism of several prescribed drugs

• Cause gastrointestinal upset at high doses

Fenugreek may also interact with anticoagulants and antidiabetic medicines. Cinnamon — particularly cassia cinnamon, the most common variety in supplements — contains coumarin, which can be hepatotoxic with prolonged use. The Food Standards Agency (FSA) has published guidance on tolerable coumarin intake; high-dose cassia cinnamon supplements may exceed safe levels.

Key safety principles to bear in mind:

• Always inform your GP or pharmacist before starting any herbal supplement, particularly if you take regular prescribed medication

• In the UK, herbal products sold as medicines should carry a Traditional Herbal Registration (THR) mark, regulated by the MHRA, which provides some assurance of quality, safety, and standardised dosing. This is distinct from herbal products sold as food supplements, which are not subject to the same pre-market assessment and may vary considerably in quality and content

• Supplements are not subject to the same rigorous pre-market testing as licensed medicines

• If you experience an unexpected reaction to a herbal product, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk

• Pregnant or breastfeeding women should avoid most herbal supplements unless specifically advised otherwise by a healthcare professional

NHS-Recommended Approaches to Reducing Visceral Fat

NICE recommends a calorie-controlled diet, at least 150 minutes of moderate aerobic activity weekly, and structured behavioural support as the primary evidence-based strategies for reducing visceral fat.

Whilst herbal remedies attract considerable public interest, the NHS and NICE provide clear, evidence-based guidance on how to effectively reduce visceral fat — and none of these recommendations involve herbal supplementation as a primary strategy.

Dietary modification is central to reducing visceral fat. NICE guidance on obesity (CG189) recommends a balanced, calorie-controlled diet that reduces overall energy intake. Diets lower in refined carbohydrates and added sugars, and higher in fibre, lean protein, and unsaturated fats, have been shown to preferentially reduce visceral adiposity. The NHS Eatwell Guide provides a practical, evidence-based framework for achieving a healthy dietary pattern.

Physical activity is equally important. Both aerobic exercise (such as brisk walking, cycling, or swimming) and resistance training have been shown to reduce visceral fat independently of weight loss. The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week, alongside muscle-strengthening activities on two or more days. Research consistently shows that exercise reduces visceral fat even when total body weight changes little.

Behavioural and psychological support — including cognitive behavioural therapy (CBT) approaches and structured weight management programmes — are recommended by NICE for individuals with obesity. NHS Tier 2 and Tier 3 weight management services offer multidisciplinary support and are accessible via GP referral.

For eligible individuals, pharmacological treatment may be considered under NICE criteria. Options include orlistat and, more recently, semaglutide (approved by NICE for weight management via Technology Appraisal) and tirzepatide (subject to current NICE appraisal). These are licensed, evidence-based medicines — a meaningful distinction from unregulated herbal supplements. Adequate sleep and stress management also play a role, as cortisol dysregulation from chronic stress is a recognised driver of visceral fat accumulation.

When to Speak to a GP or Pharmacist

Consult a GP if your waist circumference or waist-to-height ratio exceeds recommended thresholds, or before starting any herbal supplement alongside prescribed medication.

If you are concerned about visceral fat or your overall weight, speaking to a GP or pharmacist is always the most appropriate first step. Self-managing with herbal supplements without professional guidance carries risks that are easily avoided with the right support.

You should make an appointment with your GP if:

• Your waist circumference exceeds the relevant threshold for your sex and ethnicity, or your waist-to-height ratio is 0.5 or above, particularly if you have other risk factors such as high blood pressure, elevated cholesterol, or a family history of type 2 diabetes or cardiovascular disease

• You have unexplained weight gain, particularly around the abdomen — this may warrant investigation for underlying conditions such as hypothyroidism or Cushing's syndrome

• You experience rapid or unexplained changes in weight, persistent abdominal swelling, oedema, or systemic symptoms such as fatigue, excessive thirst, or jaundice, which may require more urgent assessment

• You are considering starting a herbal supplement and take prescribed medication, as your GP or pharmacist can advise on potential interactions

• You have tried lifestyle changes without success and wish to discuss NHS-supported weight management options, including referral to a structured Tier 2 or Tier 3 programme or assessment for pharmacological treatment

A pharmacist can help with:

• Reviewing your current medicines for potential interactions with herbal products

• Advising on the safety and regulatory status of specific supplements, including whether a product carries a THR mark

• Signposting to NHS weight management services in your area

• Advising on how to report adverse reactions via the MHRA Yellow Card scheme

It is worth remembering that no herbal supplement is recommended within NHS-approved treatment pathways for clinically significant visceral fat reduction. Whilst some herbs show early-stage promise in research settings, they should be viewed as adjuncts to — never replacements for — evidence-based lifestyle interventions and, where appropriate, medically supervised treatment. Your long-term health is best served by an informed, holistic approach guided by qualified healthcare professionals.

Frequently Asked Questions